Asthma increases long-term revision rates of endoscopic sinu
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Chronic rhinosinusitis with asthma (CRS-A) has a significant impact on patient morbidity and quality of life. Recent research has documented that the rate of revision of endoscopic sinus surgery (ESS) in chronic rhinosinusitis with asthma (CRS-A) was twice that of CRS without asthma (CRS-alone).

The objective of this study by the International Forum of Allergy and Rhinology was to evaluate revision rates of ESS in CRS-A and identify risk factors associated with increased likelihood for revision surgery compared to those with CRS without asthma (CRS-alone).

The Utah Population Database was queried for patients age more than 18 years with CRS who underwent at least 1 ESS. Demographic information and history of ESS were collected and compared between CRS-A and CRS-alone using chi-square tests for categorical variables and t-tests for continuous variables. Risk factors for revision surgery were analyzed using Cox proportional hazard models.

A total of 33,090 patients were included in the final analysis. The study showed;

--The revision rate among patients with CRS-A was twice that of CRS-alone.

--Among patients with CRS, a history of allergy, asthma, and nasal polyposis was independently associated with increased risk of revision ESS.

--Patients with CRS-A and nasal polyposis were 6 times more likely to require revision surgery than those with CRS-alone.

In conclusion, the rate of revision ESS in CRS-A was twice that of CRS-alone; patients with CRS-A and nasal polyposis were 6 times more likely to require revision than those with CRS-alone.

Source: https://doi.org/10.1002/alr.22779
Like
Comment
Share